Casciaro, B.; Calcaterra, A.; Cappiello, F.; Mori, M.; Loffredo, M.R.; Ghirga, F.; Mangoni, M.L.; Botta, B.; Quaglio, D.
Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections. Toxins 2019, 11, 511.
https://doi.org/10.3390/toxins11090511
AMA Style
Casciaro B, Calcaterra A, Cappiello F, Mori M, Loffredo MR, Ghirga F, Mangoni ML, Botta B, Quaglio D.
Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections. Toxins. 2019; 11(9):511.
https://doi.org/10.3390/toxins11090511
Chicago/Turabian Style
Casciaro, Bruno, Andrea Calcaterra, Floriana Cappiello, Mattia Mori, Maria Rosa Loffredo, Francesca Ghirga, Maria Luisa Mangoni, Bruno Botta, and Deborah Quaglio.
2019. "Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections" Toxins 11, no. 9: 511.
https://doi.org/10.3390/toxins11090511
APA Style
Casciaro, B., Calcaterra, A., Cappiello, F., Mori, M., Loffredo, M. R., Ghirga, F., Mangoni, M. L., Botta, B., & Quaglio, D.
(2019). Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections. Toxins, 11(9), 511.
https://doi.org/10.3390/toxins11090511